GLYCOTARGE Trademark

Trademark Overview

On Wednesday, January 31, 2024, a trademark application was filed for GLYCOTARGE with the United States Patent and Trademark Office. The USPTO has given the GLYCOTARGE trademark a serial number of 79393252. The federal status of this trademark filing is REGISTERED as of Tuesday, April 22, 2025. This trademark is owned by Pneumagen Limited. The GLYCOTARGE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research; scientific research; scientific laboratory services; medical research relating to pharmaceuticals; pharmaceutical products development; pharmaceutical research and development; drug screening for scientific research purposes; information, advice and consultancy in relation to all the aforesaid services
glycotarge

General Information

Serial Number79393252
Word MarkGLYCOTARGE
Filing DateWednesday, January 31, 2024
Status700 - REGISTERED
Status DateTuesday, April 22, 2025
Registration Number7764490
Registration DateTuesday, April 22, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2025

Trademark Statements

Goods and ServicesMedical research; scientific research; scientific laboratory services; medical research relating to pharmaceuticals; pharmaceutical products development; pharmaceutical research and development; drug screening for scientific research purposes; information, advice and consultancy in relation to all the aforesaid services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 12, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePneumagen Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NamePneumagen Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NamePneumagen Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Thursday, April 11, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 18, 2024APPLICATION FILING RECEIPT MAILED
Monday, August 26, 2024ASSIGNED TO EXAMINER
Wednesday, August 28, 2024NON-FINAL ACTION WRITTEN
Thursday, August 29, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 29, 2024REFUSAL PROCESSED BY MPU
Thursday, August 29, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, September 14, 2024REFUSAL PROCESSED BY IB
Tuesday, February 4, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 4, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 4, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 6, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 22, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, April 22, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, July 23, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, September 10, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, September 10, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, September 27, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Saturday, November 8, 2025FINAL DISPOSITION PROCESSED
Saturday, November 8, 2025FINAL DISPOSITION NOTICE SENT TO IB
Sunday, November 30, 2025FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

glycotarge research scientific pharmaceutical services medical development information advice relation aforesaid